Related references
Note: Only part of the references are listed.Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease
William R. Drobyski et al.
HAEMATOLOGICA (2018)
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease
William R. Drobyski et al.
HAEMATOLOGICA (2018)
Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease
James H. Jerkins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease
Yngvar Floisand et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V. F. Roddy et al.
LEUKEMIA & LYMPHOMA (2016)
Tocilizumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease: A Pediatric Experience
Sima Bhatt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation
C. Castilla-Llorente et al.
BONE MARROW TRANSPLANTATION (2014)
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
Glen A. Kennedy et al.
LANCET ONCOLOGY (2014)
Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine Treatment
Alienor Xhaard et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Madan Jagasia et al.
BLOOD (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
William R. Drobyski et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation
Isao Tawara et al.
CLINICAL CANCER RESEARCH (2011)
Blockade of IL-6-signaling inhibits the pathogenesis of CD4+ T cell-mediated lethal graft-versus-host reaction against minor histocompatibility antigen
Daisuke Noguchi et al.
IMMUNOLOGY LETTERS (2011)
Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease
Xiao Chen et al.
BLOOD (2009)
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation
PJ Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Share Paper
